Annex

United Kingdom

The entry corresponding to eprinomectin in Table 1 of the Annex to Regulation (EU) No 37/2010 is replaced by the following:

Pharmacologically active Substance Marker residue Animal Species MRL Target Tissues Other Provisions (according to Article 14(7) of Regulation (EC) No 470/2009) Therapeutic Classification
‘Eprinomectin Eprinomectin B1a Bovine 50 μg/kg Muscle NO ENTRY Antiparasitic agents/Agents acting against endo- and ectoparasites’
250 μg/kg Fat
1 500 μg/kg Liver
300 μg/kg Kidney
20 μg/kg Milk
Ovine, caprine 50 μg/kg Muscle The MRLs laid down for these animal species are provisional MRLs. They shall expire on 1 July 2014.
250 μg/kg Fat
1 500 μg/kg Liver
300 μg/kg Kidney
20 μg/kg Milk

Pharmacologically active Substance	Marker residue	Animal Species	MRL	Target Tissues	Other Provisions (according to Article 14(7) of Regulation (EC) No 470/2009)	Therapeutic Classification
‘Eprinomectin	Eprinomectin B1a	Bovine	50 μg/kg	Muscle	NO ENTRY	Antiparasitic agents/Agents acting against endo- and ectoparasites’
			250 μg/kg	Fat
			1 500 μg/kg	Liver
			300 μg/kg	Kidney
			20 μg/kg	Milk
		Ovine, caprine	50 μg/kg	Muscle	The MRLs laid down for these animal species are provisional MRLs. They shall expire on 1 July 2014.
			250 μg/kg	Fat
			1 500 μg/kg	Liver
			300 μg/kg	Kidney
			20 μg/kg	Milk